Pediatric Meningitis

May 5, 2011Clinical Trial, Pediatric, Vaccines

Meningitis is the inflammation of the protective membranes that surround the brain and spinal cord. The inflammation can be caused by infection associated with viruses, bacteria or other microorganisms. Meningitis can be life threatening due to the proximity to the brain and spinal cord. In children it can be especially serious because small children often dont exhibit the same symptoms as adults, but may be irritable and listless. Infants often exhibit signs with bulging of the soft spot, other symptoms may include leg pain, cold extremities and abnormal skin color.

JBR Clinical Research is performing a clinical trial to test the effectiveness of a meningitis vaccine to prevent the infection in 2 month old infants.

Pediatric Meningitis Basic Qualifications

2 month old infants (55-89 days old)
Boy or Girl
Be a full term baby (37+ weeks)
>5.5lbs at birth
Parental Consent
Ability to complete study

Qualified participants may receive:

Health care related to the study
No cost vaccination
Compensation up to $550 for time and travel related to the study

Location For Study Visits:
1255 East 3900 South
Suite #300
Salt Lake City, UT 84124

JeanBrownResearch.com

Update on COVID-19

To: Our Sponsors, CROs, Patients, and Employees

At CenExel Clinical Research, our top priorities are the safety and health of our patients and employees. For our Centers of Excellence to provide the highest quality of clinical research, we established and maintain a COVID-19 Task Force with representatives from every Center. The Task Force is charged with continuous monitoring of the pandemic and providing guidance and communication.

Our clinical operations continue, and we have implemented the following additional safety measures:

Enhanced screening of everyone entering any of our facilities before they are admitted into our offices or clinical areas
Reinforced internal communication regarding the COVID-19 situation, CDC and SHRM recommendations, digital team meetings, and the importance of using sick leave for anyone who has signs, symptoms, or recent exposure to someone with suspected or diagnosed COVID-19
Additional cleaning and disinfecting materials provided through our clinic and office areas
Cross-training and preparations for contingency plans if key staff need to stay home

We will continue to monitor the current situation, coordinate with the proper authorities, and update our policies and procedures as needed to ensure the safety of our patients and employees.

Pediatric Meningitis

Share This Resource

​Update on COVID-19

To: Our Sponsors, CROs, Patients, and Employees

Update on COVID-19